651 related articles for article (PubMed ID: 18300802)
1. Prognosis of mucinous adenocarcinoma of the prostate treated by radical prostatectomy: a study of 47 cases.
Osunkoya AO; Nielsen ME; Epstein JI
Am J Surg Pathol; 2008 Mar; 32(3):468-72. PubMed ID: 18300802
[TBL] [Abstract][Full Text] [Related]
2. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
[TBL] [Abstract][Full Text] [Related]
3. Radical prostatectomy for clinical stage T3a disease.
Freedland SJ; Partin AW; Humphreys EB; Mangold LA; Walsh PC
Cancer; 2007 Apr; 109(7):1273-8. PubMed ID: 17315165
[TBL] [Abstract][Full Text] [Related]
4. The relationship between the extent of surgical margin positivity and prostate specific antigen recurrence in radical prostatectomy specimens.
Marks RA; Koch MO; Lopez-Beltran A; Montironi R; Juliar BE; Cheng L
Hum Pathol; 2007 Aug; 38(8):1207-11. PubMed ID: 17490720
[TBL] [Abstract][Full Text] [Related]
5. Extraprostatic extension of prostatic adenocarcinoma on needle core biopsy: report of 72 cases with clinical follow-up.
Miller JS; Chen Y; Ye H; Robinson BD; Brimo F; Epstein JI
BJU Int; 2010 Aug; 106(3):330-3. PubMed ID: 20002671
[TBL] [Abstract][Full Text] [Related]
6. The combined percentage of Gleason patterns 4 and 5 is the best predictor of cancer progression after radical prostatectomy.
Cheng L; Koch MO; Juliar BE; Daggy JK; Foster RS; Bihrle R; Gardner TA
J Clin Oncol; 2005 May; 23(13):2911-7. PubMed ID: 15860849
[TBL] [Abstract][Full Text] [Related]
7. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
Tavora F; Epstein JI
Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
[TBL] [Abstract][Full Text] [Related]
8. Chromogranin A and biochemical progression-free survival in prostate adenocarcinomas submitted to radical prostatectomy.
Alessandro S; Vincenzo G; Maria AG; Stefano S; Alessandro G; Salvatore M; Vincenzo T; Franco DS
Endocr Relat Cancer; 2007 Sep; 14(3):625-32. PubMed ID: 17914093
[TBL] [Abstract][Full Text] [Related]
9. Study of prostate cancer pathologic features in Chinese populations.
Chuang AY; Chang SJ; Horng CF; Tsou MH
Urology; 2007 May; 69(5):915-20. PubMed ID: 17482934
[TBL] [Abstract][Full Text] [Related]
10. The significance of positive surgical margin in areas of capsular incision in otherwise organ confined disease at radical prostatectomy.
Chuang AY; Nielsen ME; Hernandez DJ; Walsh PC; Epstein JI
J Urol; 2007 Oct; 178(4 Pt 1):1306-10. PubMed ID: 17698141
[TBL] [Abstract][Full Text] [Related]
11. Clinical results of radical prostatectomy for patients with prostate cancer in Macau.
Ho SF; Lao HF; Li K; Tse MK
Chin Med J (Engl); 2008 Feb; 121(4):295-8. PubMed ID: 18304459
[TBL] [Abstract][Full Text] [Related]
12. Positive-block ratio in radical prostatectomy specimens is an independent predictor of prostate-specific antigen recurrence.
Marks RA; Lin H; Koch MO; Cheng L
Am J Surg Pathol; 2007 Jun; 31(6):877-81. PubMed ID: 17527074
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy.
Bastian PJ; Palapattu GS; Yegnasubramanian S; Lin X; Rogers CG; Mangold LA; Trock B; Eisenberger M; Partin AW; Nelson WG
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5361-7. PubMed ID: 17875764
[TBL] [Abstract][Full Text] [Related]
14. A pathological reassessment of organ-confined, Gleason score 6 prostatic adenocarcinomas that progress after radical prostatectomy.
Miyamoto H; Hernandez DJ; Epstein JI
Hum Pathol; 2009 Dec; 40(12):1693-8. PubMed ID: 19683331
[TBL] [Abstract][Full Text] [Related]
15. Percentage of Gleason pattern 4 and 5 predicts survival after radical prostatectomy.
Cheng L; Davidson DD; Lin H; Koch MO
Cancer; 2007 Nov; 110(9):1967-72. PubMed ID: 17823907
[TBL] [Abstract][Full Text] [Related]
16. Needle biopsy of recurrent adenocarcinoma of the prostate after radical prostatectomy.
Ripple MG; Potter SR; Partin AW; Epstein JI
Mod Pathol; 2000 May; 13(5):521-7. PubMed ID: 10824923
[TBL] [Abstract][Full Text] [Related]
17. Pleomorphic giant cell adenocarcinoma of the prostate: report of 6 cases.
Parwani AV; Herawi M; Epstein JI
Am J Surg Pathol; 2006 Oct; 30(10):1254-9. PubMed ID: 17001156
[TBL] [Abstract][Full Text] [Related]
18. A clinicopathologic study of preoperative and postoperative findings with minute Gleason 3+3=6 cancer at radical prostatectomy.
Osunkoya AO; Carter HB; Epstein JI
Urology; 2008 Sep; 72(3):638-40. PubMed ID: 18400278
[TBL] [Abstract][Full Text] [Related]
19. Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: implications for clinical management.
Aydin H; Zhang J; Samaratunga H; Tan N; Magi-Galluzzi C; Klein E; Jones JS; Zhou M
BJU Int; 2010 Feb; 105(4):476-80. PubMed ID: 19709071
[TBL] [Abstract][Full Text] [Related]
20. [Progression after radical prostatectomy of cancer of the prostate: prognostic criteria and the role of PSA in monitoring].
Fendler JP; Dujardin T; Bringeon G; Adeleine P; Devonec M; Perrin P
Prog Urol; 1992 Feb; 2(1):58-65. PubMed ID: 1284386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
